JP2017523260A5 - - Google Patents

Download PDF

Info

Publication number
JP2017523260A5
JP2017523260A5 JP2016569937A JP2016569937A JP2017523260A5 JP 2017523260 A5 JP2017523260 A5 JP 2017523260A5 JP 2016569937 A JP2016569937 A JP 2016569937A JP 2016569937 A JP2016569937 A JP 2016569937A JP 2017523260 A5 JP2017523260 A5 JP 2017523260A5
Authority
JP
Japan
Prior art keywords
compound
group
substituted
alkyl
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016569937A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017523260A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2015/050254 external-priority patent/WO2015179963A1/en
Publication of JP2017523260A publication Critical patent/JP2017523260A/ja
Publication of JP2017523260A5 publication Critical patent/JP2017523260A5/ja
Pending legal-status Critical Current

Links

JP2016569937A 2014-05-29 2015-03-31 シクロデキストリン系のポリアニオン性デンドリマーおよび非イオン性デンドリマー Pending JP2017523260A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201462004364P 2014-05-29 2014-05-29
US62/004,364 2014-05-29
US201462060787P 2014-10-07 2014-10-07
US62/060,787 2014-10-07
PCT/CA2015/050254 WO2015179963A1 (en) 2014-05-29 2015-03-31 Cyclodextrin-based polyanionic and non-ionic dendrimers

Publications (2)

Publication Number Publication Date
JP2017523260A JP2017523260A (ja) 2017-08-17
JP2017523260A5 true JP2017523260A5 (cg-RX-API-DMAC7.html) 2018-05-17

Family

ID=54697766

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016569937A Pending JP2017523260A (ja) 2014-05-29 2015-03-31 シクロデキストリン系のポリアニオン性デンドリマーおよび非イオン性デンドリマー

Country Status (5)

Country Link
US (1) US10662260B2 (cg-RX-API-DMAC7.html)
EP (1) EP3149052A4 (cg-RX-API-DMAC7.html)
JP (1) JP2017523260A (cg-RX-API-DMAC7.html)
CA (1) CA2950610A1 (cg-RX-API-DMAC7.html)
WO (1) WO2015179963A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3052530B1 (en) * 2013-10-01 2019-09-18 UTI Limited Partnership Amphiphilic cyclodextrin-based glycodendrimers
WO2016161501A1 (en) * 2015-04-08 2016-10-13 Ling Chang-Chun Pharmaceutical compositions of polyanionic and non-ionic cyclodextrin-based dendrimers and uses thereof
WO2017144734A2 (en) 2016-06-23 2017-08-31 Synthon B.V. Process for making sugammadex
BR112019001131A2 (pt) * 2016-07-22 2019-04-30 Ecole Polytechnique Federale De Lausanne (Epfl) composto virucida, composição farmacêutica, método de desinfecção e/ou esterilização, dispositivo e uso dos compostos virucidas
CN108164569A (zh) * 2018-02-08 2018-06-15 西北工业大学 一种以β-CD为核的树枝状大分子及其合成方法
WO2020048976A1 (en) 2018-09-04 2020-03-12 Ecole Polytechnique Federale De Lausanne (Epfl) Virucidal nanoparticles and use thereof against influenza virus

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6794518B1 (en) * 1998-12-18 2004-09-21 Bristol-Myers Squibb Pharma Company Vitronectin receptor antagonist pharmaceuticals
CN1356913A (zh) * 1998-12-18 2002-07-03 杜邦药品公司 玻连蛋白受体拮抗剂药物
WO2000043475A2 (en) 1999-01-20 2000-07-27 The Procter & Gamble Company Dishwashing compositions comprising modified alkylbenzene sulfonates
TWI242015B (en) 1999-11-29 2005-10-21 Akzo Nobel Nv 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
DE50113779D1 (de) * 2000-11-08 2008-05-08 Greenfield Ag Verfahren zum Befüllen eines Fahrzeugtanks mit Gas
FR2852959B1 (fr) * 2003-03-28 2008-02-15 Centre Nat Rech Scient Nouveaux derives de cyclodextrines, leur procede de preparation et leur utilisation notamment pour solubilisation de substances pharmacologiquement actives
FR2903987B1 (fr) 2006-07-21 2012-12-21 Centre Nat Rech Scient Nouveaux derives de cyclodextrines amphiphiles, leur utilisation dans les domaines pharmaceutiques,cosmetiques, alimentaires et leur application a la production de nouveaux nanosystemes
US7635773B2 (en) 2008-04-28 2009-12-22 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions
US20100056475A1 (en) * 2008-08-06 2010-03-04 Alexander Chucholowski Cyclodextrin conjugates
CN101591402B (zh) * 2009-05-05 2011-11-30 杭州奥默医药技术有限公司 6-脱氧砜类环糊精衍生物及其制备方法
US8492538B1 (en) * 2009-06-04 2013-07-23 Jose R. Matos Cyclodextrin derivative salts
DE102010012281A1 (de) * 2010-03-22 2011-09-22 Fresenius Medical Care Deutschland Gmbh Pharmazeutische Zusammensetzungen enthaltend substituiertes 6-Deoxy-6-sulfanylcyclodextrin
ES2774901T3 (es) 2012-02-15 2020-07-23 Cydex Pharmaceuticals Inc Proceso para la fabricación de derivados de ciclodextrina

Similar Documents

Publication Publication Date Title
JP2017523260A5 (cg-RX-API-DMAC7.html)
EP2588116A4 (en) BY SUBSTITUTED BETA-CYCLODEXTRIN STABILIZED INTRAVENOUS POSACONAZOLE SOLUTION FORMULATIONS
JP2016505044A5 (cg-RX-API-DMAC7.html)
PH12018500088A1 (en) Substituted tricyclics and method of use
JP2013505945A5 (cg-RX-API-DMAC7.html)
JP2016514192A5 (cg-RX-API-DMAC7.html)
JP2014511891A5 (cg-RX-API-DMAC7.html)
JP2010503698A5 (cg-RX-API-DMAC7.html)
JP2018518537A5 (cg-RX-API-DMAC7.html)
JP2013530179A5 (cg-RX-API-DMAC7.html)
JP2016506916A5 (cg-RX-API-DMAC7.html)
JP2009529540A5 (cg-RX-API-DMAC7.html)
JP2013540713A5 (cg-RX-API-DMAC7.html)
JP2014515406A5 (cg-RX-API-DMAC7.html)
MY165906A (en) Phenothiazine diaminium salts and their use
JP2016508130A5 (cg-RX-API-DMAC7.html)
JP2013514329A5 (cg-RX-API-DMAC7.html)
MX2018004364A (es) Acidos pirazolo [3,4-b] piridin-6-carboxilicos sustituidos y su uso.
CY1116683T1 (el) Φαρμακο το οποιο περιεχει ενα παραγωγο καρβοστυριλιου και δονεπεζιλη για τη θεραπεια της νοσου alzheimer
HRP20170021T1 (hr) Formulacije koje sadrže 2-amino-2-[2-(4-oktilfenil)etil]propan-1,3-diol
EA201370175A1 (ru) Клатратный комплекс циклодекстрина или арабиногалактана с 9-фенил-симм-октагидроселеноксантеном, способ его получения (варианты), фармацевтическая композиция и лекарственное средство
JP2009536221A5 (cg-RX-API-DMAC7.html)
JP2015509075A5 (cg-RX-API-DMAC7.html)
JP2010528045A5 (cg-RX-API-DMAC7.html)
JP2018507166A5 (cg-RX-API-DMAC7.html)